BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26742121)

  • 1. Comparative Profiling of Triple-Negative Breast Carcinomas Tissue Glycoproteome by Sequential Purification of Glycoproteins and Stable Isotope Labeling.
    Chen X; Wu J; Huang H; Ding Q; Liu X; Chen L; Zha X; Liang M; He J; Zhu Q; Wang S; Xia T
    Cell Physiol Biochem; 2016; 38(1):110-21. PubMed ID: 26742121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
    Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
    Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancer.
    Lin Y; Lin L; Fu F; Wang C; Hu A; Xie J; Jiang M; Wang Z; Yang L; Guo R; Yang P; Shen H
    Breast Cancer Res Treat; 2021 Jan; 185(1):39-52. PubMed ID: 32920739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease.
    Kanaan YM; Sampey BP; Beyene D; Esnakula AK; Naab TJ; Ricks-Santi LJ; Dasi S; Day A; Blackman KW; Frederick W; Copeland RL; Gabrielson E; Dewitty RL
    Cancer Genomics Proteomics; 2014; 11(6):279-94. PubMed ID: 25422359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
    Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
    PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectin RCA-I specifically binds to metastasis-associated cell surface glycans in triple-negative breast cancer.
    Zhou SM; Cheng L; Guo SJ; Wang Y; Czajkowsky DM; Gao H; Hu XF; Tao SC
    Breast Cancer Res; 2015 Mar; 17(1):36. PubMed ID: 25848723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumours.
    Provenzano E; Byrne DJ; Russell PA; Wright GM; Generali D; Fox SB
    Histopathology; 2016 Feb; 68(3):367-77. PubMed ID: 26118394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
    Li Q; Jin W; Cai Y; Yang F; Chen E; Ye D; Wang Q; Guan X
    Biochem Biophys Res Commun; 2017 Apr; 485(3):693-697. PubMed ID: 28237701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype.
    Ehmsen S; Hansen LT; Bak M; Brasch-Andersen C; Ditzel HJ; Leth-Larsen R
    Int J Cancer; 2015 Nov; 137(9):2093-103. PubMed ID: 25912829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrazide functionalized core-shell magnetic nanocomposites for highly specific enrichment of N-glycopeptides.
    Liu L; Yu M; Zhang Y; Wang C; Lu H
    ACS Appl Mater Interfaces; 2014 May; 6(10):7823-32. PubMed ID: 24735409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry.
    Huo L; Gong Y; Guo M; Gilcrease MZ; Wu Y; Zhang H; Zhang J; Resetkova E; Hunt KK; Deavers MT
    Histopathology; 2015 Aug; 67(2):245-54. PubMed ID: 25564996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of vitamin D receptor and insulin-like growth factor receptor 1 expression in triple-negative breast cancer.
    Soljic M; Mrklic I; Tomic S; Omrcen T; Sutalo N; Bevanda M; Vrdoljak E
    J Clin Pathol; 2018 Jan; 71(1):34-39. PubMed ID: 28663327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.
    Bahhnassy A; Mohanad M; Shaarawy S; Ismail MF; El-Bastawisy A; Ashmawy AM; Zekri AR
    Mol Med Rep; 2015 Jul; 12(1):851-64. PubMed ID: 25824321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric identification of N-linked glycopeptides using lectin-mediated affinity capture and glycosylation site-specific stable isotope tagging.
    Kaji H; Yamauchi Y; Takahashi N; Isobe T
    Nat Protoc; 2006; 1(6):3019-27. PubMed ID: 17406563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast Cancer.
    Ginter PS; McIntire PJ; Cui X; Irshaid L; Liu Y; Chen Z; Shin SJ
    Clin Breast Cancer; 2017 Nov; 17(7):544-549. PubMed ID: 28410844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated STC‑1 augments the invasiveness of triple‑negative breast cancer cells through activation of the JNK/c‑Jun signaling pathway.
    Han J; Jeon M; Shin I; Kim S
    Oncol Rep; 2016 Sep; 36(3):1764-71. PubMed ID: 27459971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of NY-ESO-1 in Triple-Negative Breast Cancer Is Associated with Tumor-Infiltrating Lymphocytes and a Good Prognosis.
    Lee HJ; Kim JY; Song IH; Park IA; Yu JH; Gong G
    Oncology; 2015; 89(6):337-44. PubMed ID: 26413775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Cystatin E/M with Clinicopathological Features and Prognosis in Triple-Negative Breast Cancer.
    Li Q; Zheng ZC; Ni CJ; Jin WX; Jin YX; Chen Y; Zhang XH; Chen ED; Cai YF
    Ann Clin Lab Sci; 2018 Jan; 48(1):40-44. PubMed ID: 29530995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.
    Whelan SA; Lu M; He J; Yan W; Saxton RE; Faull KF; Whitelegge JP; Chang HR
    J Proteome Res; 2009 Aug; 8(8):4151-60. PubMed ID: 19522481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.